The role of microRNAs on doxorubicin drug resistance in breast cancer.
Khadijeh JamialahmadiFatemeh ZahedipourGholamreza KarimiPublished in: The Journal of pharmacy and pharmacology (2021)
Cancer treatment methods are moving from conventional therapies to targeted therapies such as using microRNAs. MiRNAs can act as regulatory molecules to overcome breast cancer doxorubicin resistance by controlling the expression levels of genes involved in different cellular pathways. Thus, exact elucidation of their role in different cellular processes can help overcome the breast cancer development and drug resistance.